Sign Up:

Email *

* Required

First Name *

* Required

Last Name *

* Required

Company/Organization *

* Required

Job Function *

* Required

Industry *

* Required

Country *

* Required

State/Province

* Required

Are you currently performing in vivo studies with mice or rats? *

* Required

Occasionally, Taconic would like to contact you about additional technical and educational content. You may unsubscribe from these communications at anytime. If you consent, please tick one of the check boxes below: *

YesNo * Required

Taconic needs the contact information you provide in this form to respond to your request. For details please see our Privacy Policy.

* Required

To view GEN’s privacy statement click here.

* Required

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

In Vivo Genome Editing: Engineering Effectors, Guides, and Templates

Available On-Demand

Already Registered? Click HereA decade after its initial development, CRISPR genome editing is showing great promise for the treatment of previously intractable diseases, with exciting results reported in early clinical trials. However, challenges in creating precise edits (as opposed to imprecise insertions and deletions) in vivo, and in delivering the editing machinery safely and specifically to target tissues, currently limit therapeutic applications.

In this inaugural Keynote webinar hosted by GEN Biotechnology , Professor Erik Sontheimer presents his team’s advances in developing new CRISPR-Cas effectors, engineered guides, and enhanced templates that improve in vivo implementation across nuclease editing, base editing, and prime editing platforms.

Presenters

Erik Sontheimer, PhD

Professor, RNA Therapeutics Institute
UMass Chan Medical School
View Biography